Delivery Order SPE2DB22D3501-SPE2DB24FXD21
Award Date
9/26/24
Potential Completion Date
9/27/24
Potential Value
$42K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $26,497.89 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Dupixent 300 mg/2 ml pens and has a completion date of February 26, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office Division. The $40,229.42 firm fixed-price delivery order contract is for the supply of Dupixent 300 mg/2 ml pen injectors. The award is not set-aside and has an ultimate completion date of August 22, 2024. Amerisourcebergen is a major pharmaceutical distributor that provides a wide range of medical products and supplies to various government agencies, including...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,564,029,714 units of the pharmaceutical product Dupixent 300 mg/2 mL pen in 2 mL size. The award, valued at $26,354.74, has a period of performance through March 21, 2024. Amerisourcebergen Drug Corp is the prime contractor and holds an Indefinite Delivery Contract (IDC) with DLA valued at up to $999,999,999.00...
This is a $42,724.26 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The order is for the supply of Dupixent 300 mg/2 ml pens and has a period of performance through February 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,337.48 firm-fixed-price contract is for the supply of Dupixent 300 mg/2 ml pens, with a performance period through May 14, 2025. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 with the DLA Troop Support Medical, which serves as a comprehensive global pharmaceutical support...
This is a $25,097.18 firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Dupixent 300 mg/2 ml pens and has a completion date of March 6, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract with DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $9,914.10 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of Dupixent 300 mg/2 ml pens. This delivery order is part of a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00 awarded by DLA to AmerisourceBergen Drug Corp, which serves as the primary vehicle for the company to provide pharmaceutical products and medical supplies to DLA Troop...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,837.84, is for the supply of 4,567,957,202 units of the pharmaceutical product Dupixent 300 mg/2 ml pen (2 ml). The contract has an ultimate completion date of April 18, 2025. AmerisourceBergen Drug Corp is the prime contractor, and there is no set-aside designation indicated....
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of a pharmaceutical product, Dupixent 300 mg/2 ml pen 2 ml. The contract is a firm fixed-price delivery order with a ceiling value of $92,236.42 and an ultimate completion date of October 9, 2024. AmerisourceBergen, a major pharmaceutical distributor, is the prime contractor for this award. The contract does not have a set-aside designation. This delivery order appears to...
This federal contract award is for a delivery order to Amerisourcebergen Drug Corp's Corporate Office division, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $16,523.50 firm-fixed-price contract is for the delivery of Dupixent 300 mg/2 ml pens, with an ultimate completion date of September 17, 2024. This order is not associated with a set-aside program. Amerisourcebergen is a significant supplier of pharmaceutical products and medical...